MS - Biostache

Recent Articles..

Who needs a heartbeat? BiVACOR The New Artificial Titanium Heart
Heart disease remains one of the leading causes of death globally, BiVACOR may be the solution to this – a total artificial heart that utilises a single motor with MAGLEV technology to pump blood to the lungs and body.
The Micro Apocalypse: Antimicrobial Resistance
Antibiotics are arguably one of the most important biotechnological inventions of the last century. Access to effective antibiotic and antimicrobial drugs has saved countless lives, and allowed for advancements in healthcare, increasing the success of other medical interventions such as surgery and chemotherapy.
Here’s why last week’s stock market crash is a warning sign for Australia’s biotech sector
Investments in biotechnology are most impactful when made by those with deep pockets. The aim of the game is to make a return on investment, …
Read more "Here’s why last week’s stock market crash is a warning sign for Australia’s biotech sector"
How Right Were We? – A Recap Of The Most Promising Biotech Companies In 2024.
We’re halfway! As we have reached the first half of 2024, I feel it is time to revisit our previous article and check-in with the …
Read more "How Right Were We? – A Recap Of The Most Promising Biotech Companies In 2024."
FightMND’s Beanie to Cure Pipeline: Where does the money go?
Who are FightMND? FightMND are a charity co-founded by Neale Daniher, Pat Cunningham and Dr Ian Davis. The charity aims to raise money to fund …
Read more "FightMND’s Beanie to Cure Pipeline: Where does the money go?"

The PLATYPUS Trail: New MS Clinical Trial Arrives at HMRI

by Sam RubaBiotechnology, Clinical Trial, Drug Development June 12, 2024June 12, 2024No Comments

Last week Hunter Medical Research Institute (HMRI) announced that a new MS Clinical trial will begin in Newcastle, headed by Professor Jeanette Lechner-Scott.